-
Microdissection_sequencing_of_normal_human_prostate
Study
EGAS00001003049
-
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer
Study
EGAS50000000211
-
Sensitive circulating tumor DNA based residual disease detection in epithelial ovarian cancer
Study
EGAS50000000245
-
RNA sequencing of serial samples from patients enrolled in the NA-PHER2 trial
Study
EGAS50000000248
-
Localised colon cancer WES study contaning WBCs, tissue and plasma samples at different time points
Study
EGAS50000000204
-
Panel sequencing of endocrine-resistant breast cancer
Study
EGAS50000000236
-
Accelerated single cell seeding in relapsed multiple myeloma
Study
EGAS00001004404
-
A fast, affordable and minimally-invasive diagnostic test for Cancer of Unknown Primary (CUP) using DNA methylation profiling
Study
EGAS50000000257
-
DNTR sequencing data of paediatric acute lymphoblastic leukemia
Study
EGAS50000001247
-
Whole exome sequencing of small cell neuroendocrine cancer of the cervix
Study
EGAS00001003142
-
Mutational_Analysis_of_Colorectal_PDX_models
Study
EGAS00001001171
-
The polarity and specificity of antiviral T lymphocyte responses determine susceptibility to SARS-CoV-2 infection in cancer patients and healthy individuals.
Study
EGAS00001005985
-
Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer
Study
EGAS50000000297
-
CD8-targeted IL-2 unleashes tumor-specific immunity in human cancer tissue by reviving the dysfunctional T cell pool
Study
EGAS00001007712
-
BRCA1 secondary splice-site mutations
Study
EGAS50000000022
-
WGS of cord blood hematopoietic stem and progenitor cells
Study
EGAS50000000288
-
STM4 - Mouliere et al, 2018. Enhanced detection of circulating tumor DNA by fragment size analysis
Study
EGAS00001004418
-
Somatic mutations of non-malignant T cells
Study
EGAS50000000237
-
INTEGRATIVE MOLECULAR ANALYSIS OF SKIN TUMORS FROM CYLD CUTANEOUS SYNDROME PATIENTS
Study
EGAS50000000247
-
Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in cancer patients
Study
EGAS50000000286
-
Molecular underpinnings of dedifferentiation and aggressiveness in chromophobe renal cell carcinoma
Study
EGAS50000000287
-
Whole Genome Sequencing of HER2-Positive Metastatic Extramammary Paget’s Disease: A Case Report
Study
EGAS50000000243
-
Whole Exome Sequencing of 60 tumor/normal matched liver Cancers (HCC)
Study
EGAS00001003063
-
Heterogeneity and evolution of DNA mutation rates in microsatellite-stable colorectal cancer
Study
EGAS50000000284
-
The neo-open reading frame peptides that comprise the tumor framome are a rich source of neoantigens for cancer immunotherapy
Study
EGAS00001006021